The Role of CXCL12 in Breast Cancer Progression
Author Information
Author(s): Sharon A. Williams, Yuka Harata-Lee, Iain Comerford, Robin L. Anderson, Mark J. Smyth, Shaun R. McColl
Primary Institution: University of Adelaide
Hypothesis
Does CXCL12 influence breast cancer metastasis and immune response?
Conclusion
CXCL12 expression can inhibit metastasis and primary tumor growth by enhancing anti-tumor immunity.
Supporting Evidence
- CXCL12(P2G) significantly inhibited metastasis.
- Wild-type CXCL12 inhibited both metastasis and primary tumor growth.
- Increased CD8+ T cell activity was observed with wild-type CXCL12 expression.
- CXCL12 expression reduced accumulation of myeloid-derived suppressor cells.
Takeaway
CXCL12 helps fight breast cancer by boosting the immune system and stopping cancer from spreading.
Methodology
The study used a syngeneic mouse model to assess the effects of CXCL12 and its antagonist on tumor growth and metastasis.
Limitations
The study was conducted in a mouse model, which may not fully replicate human breast cancer behavior.
Participant Demographics
The study involved Balb/c mice and SCID mice.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website